
-
Vingegaard reveals concussion from Paris-Nice fall
-
Chinese EV giant BYD surpasses rival Tesla with record 2024 revenue
-
Turkey detains 1,100 people since Erdogan rival's arrest
-
Spain star Yamal still maturing after rollercoaster night
-
Sudden US aid withdrawal risking millions of lives: UNAIDS chief
-
Pushing effort to sack security chief, Israel PM alleges anti-govt plot
-
Greenland PM denounces US 'foreign interference' ahead of visit
-
US, Russia in Saudi talks on Ukraine ceasefire plan
-
Juventus roll the dice after costly Motta flop
-
Turkey detains 1,100 protesters since Erdogan rival held
-
Parisians back 'garden roads' scheme in record low turnout
-
Stock markets rise on fresh hopes for Trump's tariff approach
-
Renard expecting no let-up from Japan as Saudis eye World Cup spot
-
Former Russian defence official on trial for embezzlement
-
Proenza Schouler founders to take over at Spanish fashion brand Loewe
-
Markets fluctuate as traders prepare for 'Liberation Day'
-
New Zealand qualify for World Cup but Chris Wood injured
-
US-Russia talks on Ukraine begin in Saudi Arabia
-
S. Korea authorities deploy choppers, troops to battle wildfire
-
Ingebrigtsen Sr in the dock for abuse of Olympic champ
-
West Bank Palestinians in 'extremely precarious' situation: MSF
-
'We got distracted,' says Italian star after bizarre keeper blunder
-
Brazil's Lula to build trade ties on Japan state visit
-
Ferrari despair, Lawson axe, upbeat Albon: Chinese GP talking points
-
Jimenez at the double as Mexico down Panama
-
Mozambique leader meets opposition chief to reset relations
-
South Korea court reinstates impeached PM Han as acting president
-
Asian markets fluctuate as traders prepare for 'Liberation Day'
-
Australian army gets battle-tested US long-range missiles
-
Poch backing US to come good at World Cup after Nations woe
-
Keys and Andreeva crash out of Miami Open
-
US-Russia talks on Ukraine to begin in Saudi Arabia
-
Indigenous leaders end world voyage with prayer for nature
-
Does "vibe coding" make everyone a programmer?
-
Hijacking news: Fake media sites sow Ukraine disinformation
-
Trump's US migrant hunt spares no one from deportation
-
'Love is in the air': Woods confirms Vanessa Trump romance
-
Cavs beat Jazz to snap four-game NBA skid, Celtics and Pistons win
-
Australia rewrites plan to host 2032 Brisbane Games
-
Emotional Eala credits family for rise up WTA ranks
-
France arrests young man for suspected attack on rabbi
-
Canada down US to claim third in Nations League
-
MicroVision Announces Appointment of Industry Veteran as CTO
-
DEXIS to Showcase Cutting-Edge Innovations at IDS 2025
-
Spain edge Netherlands on penalties, set up France Nations League semi-final
-
Portugal beat Denmark in thrilling Nations League quarter-final
-
France beat Croatia on penalties to reach Nations League semi-finals
-
Aussie Open champ Keys crashes out to Philippines teen Eala
-
Spain oust Netherlands on penalties to reach Nations League semis
-
Cavs snap four-game NBA skid by beating Jazz as Pistons win

Philips losses worse than expected in 2024
Philips on Wednesday posted worse-than-expected losses in 2024, as the Dutch medical device maker bids to turn the page on a damaging recall of faulty sleep machines.
The firm reported a net loss of 698 million euros for the full year 2024, compared to the 463-million-euro loss it posted in 2023.
Chief executive Roy Jakobs noted "double-digit declines in demand in both consumer and health systems in China" as well as "a persistently challenging macro environment" as reasons for the losses.
Analysts polled by the company were expecting a full-year loss of 65 million euros and sales of 18.0 billion euros.
Total sales for 2024 came in as forecast at 18.0 billion euros, compared to the 18.1 billion euros gained in 2023.
In November, the firm had lowered its full-year sales target, blaming a drop in demand from Chinese hospitals. That caused stocks to plunge by more than 11 percent.
Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.
Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.
Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.
In April, it announced it had reached a $1.1 billion deal to settle US lawsuits from the faulty machines.
Philips got a boost the day before the results when the French agency for medical safety said it could sell its respirators in the country again.
"We strengthened our fundamentals and resolved significant US litigation relating to the Respironics recall," said Jakobs.
Looking ahead, the firm said it expected sales growth of between one and three percent.
These results would be hit by a "mid-to high-single-digit decline in China," the company warned.
"We remain confident in our long-term plan," said Jakobs.
For the fourth quarter, Philips posted a net loss of 333 million euros on sales of 5.0 billion euros.
Analysts had forecast fourth-quarter profits of 302 million euros and sales of 5.1 billion euros.
The firm has continued to shed jobs. It employed 67,823 people at the end of 2024, compared to 69,656 at the end of 2023.
B.Shevchenko--BTB